| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.9M | — | +38.7% |
| Cost of Revenue | $3.3M | — | +113.0% |
| Gross Profit | $19.7M | — | +31.2% |
| R&D Expense | $14.5M | — | +21.9% |
| SG&A Expense | $5.4M | — | +25.3% |
| Operating Income | -$9.3M | — | -20.7% |
| Pre-tax Income | -$11.7M | — | -48.4% |
| Income Tax | -$3.7M | — | -1479.9% |
| Net Income | -$8.0M | — | +2.0% |
| EPS (Basic) | -$0.17 | — | +15.0% |
| EPS (Diluted) | -$0.17 | — | +15.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.7M | -65.6% | -28.7% |
| Accounts Receivable | $14.7M | -23.4% | +43.1% |
| Current Assets | $61.5M | -25.3% | +7.2% |
| Total Assets | $139.9M | +21.6% | +42.3% |
| Current Liabilities | $84.5M | +15.5% | +49.5% |
| Total Liabilities | $137.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.1M | — | -346.9% |
| Capital Expenditures | $295K | — | +61.2% |
| Investing Cash Flow | -$16.0M | — | — |
| Financing Cash Flow | $882K | — | +1796.2% |
| Free Cash Flow | -$7.4M | — | -374.8% |
| +33.1% |
| Stockholders' Equity | $2.6M | +117.7% | +153.7% |